Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation

Stroke - United States
doi 10.1161/strokeaha.111.620468
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.

Journal of Pharmacobio-Dynamics
1992English

Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator

Surgery for Cerebral Stroke
1991English

Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator During Early Postpartum Period: A Review of the Literature

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2017English

Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate

American Journal of Cardiology
Cardiovascular MedicineCardiology
1987English

The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry

PLoS ONE
Multidisciplinary
2014English

Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).

The Japanese Journal of Pharmacology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy